The recent revision of the Declaration of Helsinki strengthened theethical obligation to provide compensation for harm of research subjects. The featured article published in thelatest issue of The Japanese Journal of Clinical Pharmacology andTherapeutics reports the current status of compensation ininvestigator-initiated clinical trials (IITs) in Japan. Jan. 5th, 2017